Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Bicara Therapeutics Inc. (BCAX) had Return on Tangible Equity of -11.83% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-55.44M |
|
-- |
|
-- |
|
$59.95M |
|
$-59.95M |
|
$4.58M |
|
$-55.38M |
|
$-55.38M |
|
$-55.44M |
|
$-55.44M |
|
$-55.44M |
|
$-55.44M |
|
$-59.95M |
|
$-59.67M |
|
67.93M |
|
67.93M |
|
$-0.82 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$503.82M |
|
$0.36M |
|
$8.42M |
|
$512.24M |
|
$43.48M |
|
-- |
|
-- |
|
$43.48M |
|
$468.77M |
|
$468.77M |
|
$468.77M |
|
65.93M |
|
| Cash Flow Statement Financials | |
$-81.71M |
|
$-84.05M |
|
$165.68M |
|
$96.69M |
|
$96.60M |
|
$-0.09M |
|
$14.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.83% |
|
|
Return on Tangible Equity |
-11.83% |
-10.82% |
|
-11.83% |
|
$7.11 |
|
$-1.20 |
|
$-1.20 |
|